Helicobacter pylori and Nonmalignant Diseases

Helicobacter

Volumn 16, Issue SUPPL. 1, 2011, Pages 33-37

  Alakkari, Alaa ^a   Zullo, Angelo ^b   O'Connor, Humphrey J ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

Author keywords

Functional dyspepsia; Gastritis; Gastroesophageal reflux disease; Peptic ulcer disease

Indexed keywords

GHRELIN; HORMONE;

APPETITE; ARTICLE; DYSPEPSIA; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PEPTIC ULCER; PHENOTYPE; PRIORITY JOURNAL; WEIGHT GAIN;

GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

HELICOBACTER PYLORI;

EID: 80052523416     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2011.00878.x     Document Type: Article

References (45)

1. Goh KL. Gastroesophageal reflux disease in Asia: a historical perspective and present challenges. J Gastroenterol Hepatol 2011;26:2-10.
2. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994;89 (Suppl. 1):S116-28.
3. Zullo A, Hassan C, Campo SMA, Morini S. Bleeding peptic ulcer in the elderly: risk factors and prevention strategies. Drugs Aging 2007;24:815-28.
4. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcers. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997;24:2-17.
5. Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol 1998;93:574-8.
6. Jang HJ, Choi MH, Shin WG, Kim KH, Chung YW, Kim KO, et al. Has peptic ulcer disease changed during the past ten years in Korea? A prospective multi-center study. Dig Dis Sci 2008;53:1527-31.
7. Arroyo MT, Forne M, de Argila CM, Feu F, Arenas J, de la Vega J, et al. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe. Helicobacter 2004;9:249-54.
8. Arents NL, Thijs JC, van Zwet AA, Kleibeuker JH. Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8year period. Eur J Gastroenterol Hepatol 2004;16:779-83.
9. Cai S, Garcia-Rodriguez LA, Masso-Gonzalez EL, Hernandez-Diaz S. Uncomplicated peptic ulcer in the UK: trends from 1997 to 2005. Aliment Pharmacol Ther 2009;30:1039-48.
10. McJunkin B, Sissoko M, Levien J, Upchurch J, Ahmed A. Dramatic decline in prevalence of Helicobacter pylori and peptic ulcer disease in an endoscopy-referral population. Am J Med 2011;124:260-4.
11. Goenka MK, Majumder S, Sethy PK, Chakraborty M. Helicobacter pylori negative, non-steroidal anti-inflammatory drug-negative peptic ulcers in India. Indian J Gastroenterol 2011;30:33-7.
12. Sbrozzi-Vanni A, Zullo A, Di Giulio E, Hassan C, Corleto V, Lahner E, et al. Low prevalence of idiopathic peptic ulcer disease: an Italian endoscopic survey. Dig Liver Dis 2010;42:773-6.
13. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81.
14. Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther 2009;29:938-46.
15. Lanas A, Garcia-Rodriguez LA, Polo-Tomas M, Ponce M, Quintero E, Perez-Aisa MA, et al. The changing face of hospitalisation due to gastrointestinal bleeding and perforation. Aliment Pharmacol Ther 2011;33:585-91.
16. Lau JY, Sung J, Hill C, Henderson C, Howden CW, Metz DC. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion 2011;84:102-13.
17. Morales-Uribe CH, Sierra-Sierra S, Hernández-Hernández AM, Arango-Durango AF, Lopez GA. Upper gastrointestinal bleeding: risk factors for mortality in two urban centers in Latin America. Rev Esp Enferm Dig 2011;103:20-4.
18. Kaviani JM, Pirastehfar M, Azari A, Saberifiroozi M. Etiology and outcome of patients with upper gastrointestinal bleeding: a study form South of Iran. Saudi J Gastronterol 2010;16:253-9.
19. Sanchez-Delgado J, Gené E, Suárez D, García-Iglesias P, Brullet E, Gallach M, et al. Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression. Am J Gastroenterol 2011;106:398-405.
20. Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010;152:101-13.
21. Møller MH, Adamsen S, Thomsen RW, Møller AM. Multicentre trial of a perioperative protocol to reduce mortality in patients with peptic ulcer perforation. Br J Surg 2011;98:802-10.
22. Sadr-Azodi O, Sundquist J, Ji J, Lundell L, Sundquist K. Risk of acute myocardial infarction and stroke after discharge from in-hospital care due to complicated and uncomplicated peptic ulcer disease. Eur J Gastroenterol Hepatol 2011;23:461-6.
23. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466.
24. Kachintorn U. Epidemiology, approach and management of functional dyspepsia in Thailand. J Gastroenterol Hepatol 2011;26:32-4.
25. Abid S, Siddiqui S, Jafri W. Discriminant value of Rome III questionnaire in dyspeptic patients. Saudi J Gastroentrol 2011;17:129-33.
26. Li X, Chen H, Lu H, Li W, Chen X, Peng Y, et al. Study on the role of inflammatory cells and mediators in post-infectious functional dyspepsia. Scand J Gastroenterol 2010;45:573-81.
27. Fock KM. Functional dyspepsia, H. pylori and post infectious FD. J Gastroenterol Hepatol 2011;26(Suppl. 3):39-41.
28. Suzuki H, Nishizawa T, Hibi T. Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia? J Gastroenterol Hepatol 2011;26:42-5.
29. Gwee KA, Teng L, Wong RK, Ho KY, Sutedja DS, Yeoh KG. The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2009;21:417-24.
30. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, et al. Second Asia-Pacific consensus guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009;24:1587-600.
31. Miura S, Sugano K, Kinoshita Y, Fock KM, Goh KL, Gibson P. Diagnosis and treatment of functional gastrointestinal disorders in the Asia-Pacific region: a survey of current practices. Asian-Pacific Topic Conference organized by Japanese Society of Gastroenterology and Asian Pacific Association of Gastroenterology. J Gastroenterol Hepatol 2011;26:2-11.
32. Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007;56:631-6.
33. Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, et al. Gastritis: the histology report. Gruppo Italiano Patologi Apparato Digerente (GIPAD); Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP). Dig Liver Dis 2011;43:S373-84.
34. Pizzolitto S, Camilot D, DeMaglio G, Falconieri G. Russell body gastritis: expanding the spectrum of Helicobacter pylori- related diseases? Pathol Res Pract 2007;203:457-60.
35. Gobbo AD, Elli L, Braidotti P, Nuovo FD, Bosari S, Romagnoli S. Helicobacter pylori-negative Russell body gastritis: case report. World J Gastroenterol 2011;17:1234-6.
36. Scarpa M, Angriman I, Prando D, Polese L, Ruffolo C, Pilon F, et al. Helicobacter pylori and gastroesophageal reflux disease: a cross sectional study. Hepatogastroenterology 2011;58:69-75.
37. Jonaitis L, Kupčinskas J, Kiudelis G, Kupčinskas L. De novo esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not related to Helicobacter pylori eradication: a one year follow up study. Medicina (Kaunas) 2010;46:454-9.
38. Chourasia D, Misra A, Tripathi S, Krishnani N, Ghoshal UC. Patients with Helicobacter pylori infection have less severe gastroesophageal reflux disease: a study using endoscopy, 24-hour gastric and esophageal pH metry. Indian J Gastroenterol 2011;30:12-21.
39. Lee A, Dixon MF, Danon SJ, Kuipers E, Mégraud F, Larsson H, et al. Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol 1995;7:461-5.
40. Ghoshal UC, Chourasia D. Gastroesophageal reflux disease and Helicobacter pylori: what may be the relationship? J Neurogastroenterol Motil 2010;16:243-50.
41. Lee HL, Eun CS, Lee OY, Jeon YC, Han DS, Yoon BC, et al. Association between erosive esophagitis and visceral fat accumulation quantified by abdominal CT scan. J Clin Gastroenterol 2009;43:240-3.
42. Chung SJ, Kim D, Park MJ, Kim YS, Kim JS, Jung HC, et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008;57:1360-5.
43. Gunji T, Sato H, Iijima K, Fujibayashi K, Okumura M, Sasabe N, et al. Risk factors for erosive esophagitis: a cross-sectional study of a large number of Japanese males. J Gastroenterol 2011;46:448-55.
44. Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P, Harvey RF. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther 2011;33:922-9.
45. Jeffery PL, McGuckin MA, Linden SK. Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin o-acyltransferase. World J Gastroenterol 2011;17:1249-60.